10 results on '"Schilder, Anne"'
Search Results
2. Acute middle ear infection in children.
- Author
-
Venekamp, Roderick P., Schilder, Anne G. M., den Heuvel, Maaike van, and Hay, Alastair D.
- Subjects
ANTIBIOTICS ,OTITIS media diagnosis ,EARACHE ,MIDDLE ear ,ORAL drug administration ,OTITIS media ,OTITIS media with effusion ,OTOSCOPY ,PAIN management ,DISEASE relapse ,CONTINUING education units ,DISEASE complications ,CHILDREN - Published
- 2020
- Full Text
- View/download PDF
3. Acute middle ear infection (acute otitis media) in children.
- Author
-
Venekamp, Roderick P., Schilder, Anne G. M., van den Heuvel, Maaike, and Hay, Alastair D.
- Subjects
ANTIBIOTICS ,OTITIS media diagnosis ,IMMUNE system ,IMMUNIZATION ,MEDICAL referrals ,OTITIS media ,OTITIS media with effusion ,OTOSCOPY ,PARENTS ,RISK assessment ,TYMPANIC membrane ,PAIN management ,ACUTE diseases ,DISEASE complications ,CHILDREN - Published
- 2020
- Full Text
- View/download PDF
4. A multi-centre, pragmatic, three-arm, individually randomised, non-inferiority, open trial to compare immediate orally administered, immediate topically administered or delayed orally administered antibiotics for acute otitis media with discharge in children: The Runny Ear Study (REST): study protocol.
- Author
-
Curtis, Kathryn, Moore, Michael, Cabral, Christie, Curcin, Vasa, Horwood, Jeremey, Morris, Richard, Prasad, Vibhore, Schilder, Anne, Turner, Nicholas, Wilkes, Scott, Hay, Alastair D., and Taylor, Jodi
- Subjects
ACUTE otitis media ,ANTIBIOTICS ,CLARITHROMYCIN ,DRUG resistance in microorganisms ,ELECTRONIC health records ,WORKFLOW management ,CIPROFLOXACIN - Abstract
Background: Acute otitis media (AOM) is a common painful infection in children, with around 2.8 million cases presenting to primary care in England and Wales annually. Nearly all children who present to their general practitioner (GP) with AOM or AOM with discharge (AOMd) are treated with orally administered antibiotics. These can cause side effects; contribute to the growing problem of antimicrobial resistance, and more rarely, allergic reactions. Alternative treatments, such as an antibiotic eardrops, or 'delayed' orally administered antibiotics, could be at least as effective and safe as immediate orally administered antibiotics for children with AOMd.Methods/design: REST is a pragmatic, three-arm, individually randomised, non-inferiority trial being conducted in 175 GP practices across the United Kingdom (UK). The study aims to recruit 399 children aged (≥ 12 months and < 16 years) presenting to their GP with AOMd. Children will be randomised to one of three arms: immediate ciprofloxacin 0.3% eardrops; delayed orally administered amoxicillin (clarithromycin if penicillin allergic) or immediate orally administered amoxicillin (clarithromycin). Recruitment, including eligibility screening, randomisation and data collection, are conducted using the innovative, TRANSFoRm electronic trial management platform. Integrated within the primary care electronic medical records it provides automatic eligibility checking, part-filling of e-CRFs, study workflow management and routine NHS follow-up data collection. The primary outcome is time to resolution of all significant symptoms and will be collected by the parent using a Symptom Recovery Questionnaire (SRQ). Secondary outcomes, including cost-effectiveness, duration of moderately bad or worse symptoms and repeat AOMd episodes, will be collected at day-14 and at 3 months.Discussion: It is unclear whether prescribing orally administered antibiotics to children with AOMd results in a reduction in symptoms or a shorter duration of illness. The REST trial should allow us to compare the non-inferiority of: immediate topically administered ciprofloxacin ear drops, or delayed orally administered amoxicillin (clarithromycin) against immediate orally administered amoxicillin (clarithromycin). We aim to recruit 399 patients from 175 practices in the UK. Using the TRANSFoRm software to randomise participants to the trial will enable recruitment for a relatively uncommon condition.Trial Registration: Name of Registry: ISCRTN Registration Number: ISRCTN12873692. This contains all items required to comply with the World Health Organization Trial Registration Data Set Date of Registration: 24 April 2018 Name of Registry: EudraCT Registration Number: 2017-003635-10 Date of Registration: 6 September 2017. [ABSTRACT FROM AUTHOR]- Published
- 2020
- Full Text
- View/download PDF
5. Impact of acute otitis media clinical practice guidelines on antibiotic and analgesic prescriptions: a systematic review.
- Author
-
Deniz, Yelin, van Uum, Rick T., de Hoog, Marieke L. A., Schilder, Anne G. M., Damoiseaux, Roger A. M. J., and Venekamp, Roderick P.
- Subjects
ACUTE otitis media ,ANTIBIOTICS ,ANALGESICS ,JUVENILE diseases ,SCIENTIFIC observation - Abstract
Background: Clinical practice guidelines focusing on judicious use of antibiotics for childhood acute otitis media (AOM) have been introduced in many countries around the world.Objective: To systematically review the effects of these guidelines on the prescription of antibiotics and analgesics for children with AOM.Methods: Systematic searches of PubMed, Embase and Cochrane Library from inception to 6 June 2017 using broad search terms. Studies specifically aimed at evaluating the effects of introduction of national AOM practice guidelines on type of antibiotic and/or analgesic prescriptions were included, irrespective of design, setting or language. The Risk Of Bias In Non-randomized Studies of Interventions tool was used to assess risk of bias.Results: Of 411 unique records retrieved, seven studies conducted in six different countries (France, Italy, Spain, Sweden, UK and USA (twice)) compared data before and after guideline introduction. All studies had an observational design, using longitudinal data of children aged under 15 years (n=200-4.6 million) from either routine care, insurance databases or electronic surveys. Risk of bias of all studies was judged serious to critical.Of the five studies reporting on antibiotic prescription rates, three showed a decline of 5%-12% up to 3 years after guideline introduction and two found no or negligible effect. In one US study, the initial 9% decline decreased to 5% after 4-6 years. The recommended first choice antibiotic was prescribed more frequently (9%-58% increase) after guideline introduction in four out of five studies reporting on this outcome. Analgesic prescription rates for AOM were reported in one US study and increased from 14% to 24% after guideline introduction.Conclusion: Based upon what is published, the effects of introduction of national clinical practice guidelines on antibiotic and analgesic prescribing for children with AOM seem modest at the most.Registration: PROSPERO: CRD42016050976. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
6. Antibiotic prescribing in patients with self-reported sore throat.
- Author
-
Mehta, Nishchay, Schilder, Anne, Fragaszy, Ellen, Evans, Hannah E. R., Dukes, Oliver, Manikam, Logan, Little, Paul, Smith, Sarah C., Hayward, Andrew, and E R Evans, Hannah
- Subjects
- *
ANTIBIOTICS , *THROAT diseases , *DISEASE incidence , *MEDICAL consultation , *CHRONICALLY ill , *THERAPEUTICS , *CHRONIC diseases , *LONGITUDINAL method , *MEDICAL prescriptions , *PAIN , *PHARYNGITIS , *RESEARCH funding , *SELF-evaluation - Abstract
Objectives: To investigate the predictors of general practitioner (GP) consultation and antibiotic use in those developing sore throat.Methods: We conducted a prospective population-based cohort study on 4461 participants in two rounds (2010-11) from 1897 households.Results: Participants reported 2193 sore throat illnesses, giving a community sore throat incidence of 1.57/ person-year. 13% of sore throat illnesses led to a GP consultation and 56% of these consultations led to antibiotic use. Participants most likely to have sore throats included women and children (e.g. school compared with retirement age); adjusted incidence rate ratio (aIRR) of 1.33 and 1.52, respectively. Participants with sore throat were more likely to consult their GP if they were preschool compared with retirement age [adjusted OR (aOR) 3.22], had more days of sore throat (aOR 1.11), reported more severe pain (aOR 4.24) or reported fever (aOR 3.82). Antibiotics were more often used by chronically ill individuals (aOR 1.78), those reporting severe pain (aOR 4.14), those reporting fever (aOR 2.58) or children with earache (aOR 1.85). Among those who consulted, males and adults who reported feeling anxious were more likely to use antibiotics; aOR 1.87 and 5.36, respectively.Conclusions: Only 1 in 10 people who have a sore throat see a doctor and more than half of those attending get antibiotics. Further efforts to curb antibiotic use should focus on reducing initial GP consultations through public information promoting safe self-management, targeted at groups identified above as most likely to attend with sore throats. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
7. Antibiotic Treatment for First Episode of Acute Otitis Media Is Not Associated with Future Recurrences.
- Author
-
te Molder, Marthe, de Hoog, Marieke L. A., Uiterwaal, Cuno S. P. M., van der Ent, Cornelis K., Smit, Henriette A., Schilder, Anne G. M., Damoiseaux, Roger A. M. J., and Venekamp, Roderick P.
- Subjects
ACUTE otitis media ,ANTIBIOTICS ,DISEASE relapse ,DRUG efficacy ,DRUG prescribing ,THERAPEUTICS - Abstract
Objective: Antibiotic treatment of acute otitis media (AOM) has been suggested to increase the risk of future AOM episodes by causing unfavorable shifts in microbial flora. Because current evidence on this topic is inconclusive and long-term follow-up data are scarce, we wanted to estimate the effect of antibiotic treatment for a first AOM episode occurring during infancy on AOM recurrences and AOM-related health care utilization later in life. Methods: We obtained demographic information and risk factors from data of the Wheezing Illnesses Study Leidsche Rijn, a prospective birth cohort study in which all healthy newborns born in Leidsche Rijn (between 2001 and 2012), The Netherlands, were enrolled. These data were linked to children’s primary care electronic health records up to the age of four. Children with at least one family physician-diagnosed AOM episode before the age of two were included in analyses. The exposure of interest was the prescription of oral antibiotics (yes vs no) for a child’s first AOM episode before the age of two years. Results: 848 children were included in analyses and 512 (60%) children were prescribed antibiotics for their first AOM episode. Antibiotic treatment was not associated with an increased risk of total AOM recurrences (adjusted rate ratio: 0.94, 95% CI: 0.78–1.13), recurrent AOM (≥3 episodes in 6 months or ≥4 in one year; adjusted risk ratio: 0.79, 95% CI: 0.57–1.11), or with increased AOM-related health care utilization during children’s first four years of life. Conclusions: Oral antibiotic treatment of a first AOM episode occurring during infancy does not affect the number of AOM recurrences and AOM-related health care utilization later in life. This information can be used when weighing the pros and cons of various AOM treatment options. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
8. Addressing resistance to antibiotics in systematic reviews of antibiotic interventions.
- Author
-
Leibovici, Leonard, Paul, Mical, Garner, Paul, Sinclair, David J., Afshari, Arash, Pace, Nathan Leon, Cullum, Nicky, Williams, Hywel C., Smyth, Alan, Skoetz, Nicole, Del Mar, Chris, Schilder, Anne G. M., Yahav, Dafna, and Tovey, David
- Subjects
ANTIBIOTICS ,MEDICAL care ,DRUG resistance in bacteria ,DRUG efficacy ,RANDOMIZED controlled trials ,CLINICAL trials ,DRUG resistance in microorganisms ,MENTAL health surveys ,GENETIC mutation ,RESEARCH funding ,TREATMENT effectiveness ,DISEASE prevalence - Abstract
Antibiotics are among the most important interventions in healthcare. Resistance of bacteria to antibiotics threatens the effectiveness of treatment. Systematic reviews of antibiotic treatments often do not address resistance to antibiotics even when data are available in the original studies. This omission creates a skewed view, which emphasizes short-term efficacy and ignores the long-term consequences to the patient and other people. We offer a framework for addressing antibiotic resistance in systematic reviews. We suggest that the data on background resistance in the original trials should be reported and taken into account when interpreting results. Data on emergence of resistance (whether in the body reservoirs or in the bacteria causing infection) are important outcomes. Emergence of resistance should be taken into account when interpreting the evidence on antibiotic treatment in randomized controlled trials or systematic reviews. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
9. Clarithromycin and endoscopic sinus surgery for adults with chronic rhinosinusitis with and without nasal polyps: study protocol for the MACRO randomised controlled trial.
- Author
-
Philpott, Carl, le Conte, Steffi, Beard, David, Cook, Jonathan, Sones, William, Morris, Steve, Clarke, Caroline S., Thomas, Mike, Little, Paul, Vennik, Jane, Lund, Valerie, Blackshaw, Helen, Schilder, Anne, Durham, Stephen, Denaxas, Spiros, Carpenter, James, Boardman, James, Hopkins, Claire, and MACRO programme team
- Subjects
CLARITHROMYCIN ,SINUSITIS ,NASAL polyps ,RANDOMIZED controlled trials ,ANTIBIOTICS - Abstract
Background: Chronic rhinosinusitis (CRS) is a common source of ill health; 11% of UK adults reported CRS symptoms in a worldwide population study. Guidelines are conflicting regarding whether antibiotics should be included in primary medical management, reflecting the lack of evidence in systematic reviews. Insufficient evidence to inform the role of surgery contributes to a fivefold variation in UK intervention rates. The objective of this trial is to establish the comparative effectiveness of endoscopic sinus surgery (ESS) or a prolonged course of antibiotics (clarithromycin) in adult patients with CRS in terms of symptomatic improvement and costs to the National Health Service compared with standard medical care (intranasal medication) at 6 months.Methods/design: A three-arm parallel-group trial will be conducted with patients who remain symptomatic after receiving appropriate medical therapy (either in primary or secondary care). They will be randomised to receive: (1) intranasal medication plus ESS, (2) intranasal medication plus clarithromycin (250 mg) or (3) intranasal medication plus a placebo. Intranasal medication (current standard medical care) is defined as a spray or drops of intranasal corticosteroids and saline irrigations. The primary outcome measure is the SNOT-22 questionnaire, which assesses disease-specific health-related quality of life. The study sample size is 600. Principal analyses will be according to the randomised groups irrespective of compliance. The trial will be conducted in at least 16 secondary or tertiary care centres with an internal pilot at six sites for 6 months.Discussion: The potential cardiovascular side effects of macrolide antibiotics have been recently highlighted. The effectiveness of antibiotics will be established through this trial, which may help to reduce unnecessary usage and potential morbidity. If ESS is shown to be clinically effective and cost-effective, the trial may encourage earlier intervention. In contrast, if it is shown to be ineffective, then there should be a significant reduction in surgery rates. The trial results will feed into the other components of the MACRO research programme to establish best practice for the management of adults with CRS and design the ideal patient pathway across primary and secondary care.Trial Registration: ISRCTN36962030 . Registered on 17 October 2018. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
10. Clinical failure is more common in young children with acute otitis media who receive a short course of antibiotics compared with standard duration.
- Author
-
Venekamp, Roderick P. and Schilder, Anne G. M.
- Subjects
ANTIBIOTICS ,DRUG resistance in microorganisms ,OTITIS media ,PEDIATRICS ,TREATMENT effectiveness ,TREATMENT duration - Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.